Human Bocavirus

This stool qPCR test detects human bocavirus DNA and estimates the amount in the sample. A positive result can occur during illness or without symptoms. Its usefulness for identifying the cause of diarrhea or guiding treatment remains exploratory.

Most evidence comes from young children with acute diarrhea. Evidence for using this test to explain persistent diarrhea in adults, monitor recovery, or screen healthy people is limited. Research assays can detect the DNA accurately without establishing whether the virus caused someone's symptoms.

What the Test Picks Up

Human bocavirus stores its genetic information as a single strand of DNA. Four types have been described. Type 1 causes respiratory infections, mainly in young children, and can also appear in stool. Types 2, 3, and 4 are detected mainly in stool, although their roles in intestinal disease remain uncertain.

Quantitative PCR repeatedly copies a selected stretch of DNA to estimate how much was present. This test measures viral DNA in collected stool. It does not establish that infectious virus is present or that the virus is multiplying in the intestinal lining.

The catalog lists the unit as CFU/g stool. CFU normally describes colonies grown from living microbes, which is not what viral qPCR measures. The laboratory needs to clarify this reporting convention and its calibration before the numerical result can be interpreted. Published viral genome-copy measurements cannot be assumed to match this unit.

The catalog does not specify which bocavirus types the assay detects or whether it distinguishes them. A general positive result cannot be assigned to type 2 without separate typing information. Detection limits and accuracy reported for research assays also cannot be assumed to apply to this particular test.

Diarrhea in Young Children

Several case-control studies found bocavirus DNA in stool at similar rates in children with and without diarrhea. These studies weaken the case for treating every positive result as an explanation for illness, though they don't exclude a disease-causing role in some infections.

A Brazilian case-control study also found similar detection rates, with the virus present in 8.4% of children with diarrhea and 11.4% without it. In a separate investigation of childcare gastroenteritis outbreaks, 4.6% of stool samples contained bocavirus, but the investigators could not attribute any outbreak to it.

Persistent shedding and infections without symptoms can complicate these comparisons. A small longitudinal study documented bocavirus DNA in an otherwise healthy infant's stool for weeks. A positive result in someone who feels well can reflect an infection without symptoms or prolonged detection after an earlier infection; it doesn't reliably date that infection.

Type 2 and the Gut

Type 2 has a more consistent association with diarrhea than the other types. In the 2017 pooled analysis, children with acute gastroenteritis had about 70% higher odds of type 2 detection than controls. This was an association in stool PCR studies, not proof that type 2 caused each child's illness or that the amount measured predicts severity.

An early Australian case-control study found type 2 in 17.2% of children with diarrhea and 8.1% of matched controls. The matched analysis found about two and a half times the odds of detection, without adjustment for other pathogens. Type 3 showed no clear association.

The UK results were less straightforward than a simple negative finding. Among samples that could be typed, type 2 was more common in diarrhea cases, but about two thirds of all positive samples could not be typed, probably because they contained little DNA. The authors concluded that their study did not establish bocaviruses as a major cause of gastroenteritis in that population.

Small studies have also detected viral messenger RNA in stool. Messenger RNA is produced when viral genes are used to make proteins. This supports the possibility of intestinal replication, but it is a different measurement from this DNA test and does not establish that a positive stool DNA result diagnoses bocavirus diarrhea.

Other Germs Often Appear Alongside It

In one Brazilian study, about four out of five bocavirus-positive stool samples also contained another gut virus. In samples containing two viruses, bocavirus DNA amounts were lower than the amounts measured for rotavirus, norovirus, or adenovirus. Those comparisons used the study's own assays and do not establish a rule for choosing the cause of illness from whichever number is largest.

In about 3,800 South African children hospitalized with diarrhea, bocavirus detection was associated with roughly twice the odds of detecting bacteria or sapovirus after adjustment for several demographic and study factors. This pattern makes it difficult to separate bocavirus's contribution from that of established causes of diarrhea.

Transplant Recipients and Weakened Immunity

A small study collected stool and serum samples from 19 donor stem cell transplant recipients over a two-year study period. Eight had bocavirus DNA detected in stool, serum, or both. Stool shedding lasted a median of 26 days, with observed durations from 5 to 121 days.

Six of the eight positive participants had diarrhea when bocavirus was detected in stool. In most cases, DNA was detected in stool earlier than in serum. This suggests a possible role for stool testing in selected transplant evaluations, but the study did not establish that bocavirus caused the diarrhea or that routine screening improved care. Earlier detection in stool also does not prove that infection spread from the gut into the blood.

Respiratory Findings Need Separate Interpretation

Type 1 can cause bronchiolitis, wheezing illnesses, and pneumonia in young children. Its presence in stool during a respiratory infection may partly reflect swallowed airway secretions. Stool DNA alone cannot determine where the virus is multiplying.

Some studies of nose and throat samples found that higher viral amounts were associated with more severe respiratory illness and a greater need for oxygen. A pneumonia study found an association with viral messenger RNA after accounting for other factors, while DNA detection alone did not show that association. These findings concern airway specimens and, in part, a different molecular target. They do not validate stool DNA amounts as a measure of respiratory or intestinal disease severity.

What the Amount Can Show

The numerical result describes the DNA detected under that laboratory's testing conditions. Stool studies have not established a validated amount that separates incidental detection from diarrhea caused by bocavirus. Finding it alone can make it a candidate explanation, but the strength of that inference depends on which other causes were investigated. A larger or rising result cannot, by itself, confirm active intestinal disease.

When Results Can Be Misleading

• Detection without current disease: DNA can remain detectable after an illness or appear during an infection without symptoms. A positive result does not establish contagiousness.
• Swallowed respiratory material: type 1 DNA in stool may come from airway secretions, so the specimen does not necessarily identify the site of infection.
• Low amounts, interference, and contamination: DNA near an assay's detection limit may be detected inconsistently. Substances in stool can interfere with DNA copying, while contamination can introduce DNA that was not in the original sample.
• Collection and laboratory differences: collection medium, storage, DNA extraction, the types covered, and calibration can affect the result. Numbers from different laboratories or specimen types are not interchangeable, and a qualitative positive or negative result provides no quantity to compare.